PL378711A1 - Proces wytwarzania bezpostaciowej formy leku inhibitującego agregację płytek krwi - Google Patents

Proces wytwarzania bezpostaciowej formy leku inhibitującego agregację płytek krwi

Info

Publication number
PL378711A1
PL378711A1 PL378711A PL37871104A PL378711A1 PL 378711 A1 PL378711 A1 PL 378711A1 PL 378711 A PL378711 A PL 378711A PL 37871104 A PL37871104 A PL 37871104A PL 378711 A1 PL378711 A1 PL 378711A1
Authority
PL
Poland
Prior art keywords
preparation
platelet aggregation
amorphous form
aggregation inhibitor
inhibitor drug
Prior art date
Application number
PL378711A
Other languages
English (en)
Inventor
Nagy Peter Kotay
Gyula Simig
Jozsef Barkoczy
Tamas Gregor
Bela Farkas
Donath Györgyi Vereczkeyne
Kalman Nagy
Gyulane Körtvelyessy
Zsuzsanna Szent-Kirallyi
Original Assignee
Egis Gyorgyszergyar Rt.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from HU0302029A external-priority patent/HU0302029D0/hu
Priority claimed from HU0401269A external-priority patent/HU226565B1/hu
Application filed by Egis Gyorgyszergyar Rt. filed Critical Egis Gyorgyszergyar Rt.
Publication of PL378711A1 publication Critical patent/PL378711A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
PL378711A 2003-07-02 2004-06-30 Proces wytwarzania bezpostaciowej formy leku inhibitującego agregację płytek krwi PL378711A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0302029A HU0302029D0 (en) 2003-07-02 2003-07-02 Amorphous form of an anticoagulant agent
HU0401269A HU226565B1 (en) 2004-06-23 2004-06-23 Process for the production of the amorphous form of clopidogrel hydrogen sulfate

Publications (1)

Publication Number Publication Date
PL378711A1 true PL378711A1 (pl) 2006-05-15

Family

ID=89985325

Family Applications (1)

Application Number Title Priority Date Filing Date
PL378711A PL378711A1 (pl) 2003-07-02 2004-06-30 Proces wytwarzania bezpostaciowej formy leku inhibitującego agregację płytek krwi

Country Status (11)

Country Link
US (1) US7396931B2 (pl)
EP (1) EP1648903A2 (pl)
JP (1) JP2007516166A (pl)
KR (1) KR20060026121A (pl)
BG (1) BG109428A (pl)
CA (1) CA2530446A1 (pl)
CZ (1) CZ200660A3 (pl)
EA (1) EA200600137A1 (pl)
PL (1) PL378711A1 (pl)
SK (1) SK50112006A3 (pl)
WO (1) WO2005003138A2 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7943567B2 (en) 2004-01-30 2011-05-17 E.I. Du Pont De Nemours And Company Production processes and systems, compositions, surfactants, monomer units, metal complexes, phosphate esters, glycols, aqueous film forming foams, and foam stabilizers
US8318656B2 (en) 2007-07-03 2012-11-27 E. I. Du Pont De Nemours And Company Production processes and systems, compositions, surfactants, monomer units, metal complexes, phosphate esters, glycols, aqueous film forming foams, and foam stabilizers

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2623810B2 (fr) * 1987-02-17 1992-01-24 Sanofi Sa Sels de l'alpha-(tetrahydro-4,5,6,7 thieno(3,2-c) pyridyl-5) (chloro-2 phenyl) -acetate de methyle dextrogyre et compositions pharmaceutiques en contenant
FR2779726B1 (fr) 1998-06-15 2001-05-18 Sanofi Sa Forme polymorphe de l'hydrogenosulfate de clopidogrel
SI20814A (sl) 2001-01-23 2002-08-31 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Priprava amorfnega atorvastatina
CN100338068C (zh) 2001-01-24 2007-09-19 卡地拉健康护理有限公司 制备氯吡格雷的方法
GB0125708D0 (en) * 2001-10-26 2001-12-19 Generics Uk Ltd Novel compounds and processes
ES2316650T3 (es) * 2001-12-18 2009-04-16 Teva Pharmaceutical Industries Ltd. Polimorfos de hidrogenosulfato de clopidogrel.
EP1603920A1 (en) 2003-03-12 2005-12-14 Cadila Healthcare Ltd. Polymorph and amorphous form of (s)-(+)-clopidogrel bisulfate

Also Published As

Publication number Publication date
WO2005003138A3 (en) 2005-03-24
EA200600137A1 (ru) 2006-06-30
CZ200660A3 (cs) 2006-05-17
US7396931B2 (en) 2008-07-08
KR20060026121A (ko) 2006-03-22
SK50112006A3 (sk) 2006-05-04
CA2530446A1 (en) 2005-01-13
BG109428A (en) 2006-10-31
WO2005003138A2 (en) 2005-01-13
EP1648903A2 (en) 2006-04-26
US20070117837A1 (en) 2007-05-24
JP2007516166A (ja) 2007-06-21

Similar Documents

Publication Publication Date Title
EP1646276A4 (en) NEBULIZER FOR THE PRODUCTION OF AEROSOL DRUG
TWI318571B (en) Formulation of a thienopyridine platelet aggregation inhibitor
IL169484A0 (en) Process for modifying drug crystal formation
IL166058A0 (en) Novel thiophenylglycoside derivatives methods for production thereof medicaments comprising said compounds and use thereof
IL216449A0 (en) Process for the preparation of tetrazole derivatives
PL1737850T3 (pl) Nowy sposób wytwarzania linezolidu i związków pokrewnych
IL178458A (en) Pharmacy kit for the use of oral contraceptives in a woman
TWI345975B (en) Crystalline micronisate, process for the manufacture thereof and use thereof for the preparation of a medicament
HK1092078A1 (en) Methods of inhibiting the adherence of lenses to their packaging materials
TWI347359B (en) Methods of inhibiting the adherence of lenses to their packaging
HK1108580A1 (en) A process for the preparation of [1,4,5]-oxadiazepine derivatives
IL172629A0 (en) Process for the preparation of nonpeptide substituted spirobenzoazepine derivatives
PT1686950E (pt) Método de formação de um produto dentário
AU2003234983A1 (en) A package for articles of substantially parallelepipedal shape
PL378711A1 (pl) Proces wytwarzania bezpostaciowej formy leku inhibitującego agregację płytek krwi
HK1078853A1 (en) A new process for the preparation of epothilone derivatives
HK1095145A1 (en) Process for the preparation of n-arylmorpholinones n-
GB0129273D0 (en) Crystalline drug form
PL377755A1 (pl) Cykloalkilo-podstawione pochodne kwasów alkanowych, sposób ich wytwarzania i ich zastosowanie, jako środka leczniczego
AU2003223702A1 (en) Inhibition of platelet aggregation
PL1641438T3 (pl) Sposób wytwarzania amorficznej postaci leku
GB0314531D0 (en) Process for the preparation of a cosmetic active
AU2002339693A1 (en) A process for the preparation of polyaniline salt
AU2003223104A1 (en) A process for the preparation of indolymaleimides
IL174980A0 (en) Process for the preparation of a trifluoromethylthioether

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)